# Addition Therapeutics funding rounds and investors

As of 14 Oct 2026, Addition Therapeutics has raised $100M across 1 verified round on record; latest: $100 million Series A, announced 17 Dec 2025.

Additiontx sells genetic medicines using their PRINT technology to address severe lifelong diseases in patients.

Website: https://additiontx.com  
Page: https://fireround.dev/companies/additiontx.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2025-12-17 | Series A | $100 million | not stated | Abingworth, Pivotal Life Sciences, SR One | [biopharmadive.com](https://www.biopharmadive.com/news/addition-therapeutics-financing-rna-lipid-nanoparticle-gene-therapy/808038) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.